We wouldn`t know how to describe in short and simple words what CITES has contributed and continues to contribute to our startup.

In our experience, CITES is a great alternative to translate our ideas into reality, after having worked on developing and planning them for so long, so we can start to walk down the right path to real impact.

With CITES, we have been able to take our academic research to the entrepreneurial world, hand in hand with the growth of our startup, and promoting its development, following an efficient model that puts us in a good position at an international level.

CITES has become a technological partner who was much more than an investor; they helped us from scratch to improve the idea and the prototype and with them we were able to build GBOT.

CITES' expertise and advice was key to the establishment and success of Ergo. They even worked hard on refining our strategy and business plan prior to the investment committee.

CITES was an ally who helped us transform our scientific research into an innovative therapy. Being part of its ecosystem, working as a team day by day, provides continuous learning that turns each challenge into an enjoyable job.

Incubating in CITES was the right decision. We are convinced that coming across CITES was a catalyst to accelerate the startup and be one step closer to fulfilling our dream: starting clinical trials in humans with an innovative drug.